How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program | Zendy

Marcello Tonelli | Zendy; Sanjay Kumar Agarwal | Zendy; Alan Cass | Zendy; Guillermo García-García | Zendy; Vivekanand Jha | Zendy; Saraladevi Naicker | Zendy; Haiyan Wang | Zendy; Chih-Wei Yang | Zendy; Dónal O’Donoghue | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program

Author(s) -

Marcello Tonelli,

Sanjay Kumar Agarwal,

Alan Cass,

Guillermo García-García,

Vivekanand Jha,

Saraladevi Naicker,

Haiyan Wang,

Chih-Wei Yang,

Dónal O’Donoghue

Publication year - 2013

Publication title -

kidney international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.499

H-Index - 276

eISSN - 1523-1755

pISSN - 0085-2538

DOI - 10.1038/ki.2012.488

Subject(s) - kidney disease , medicine , intensive care medicine , chronic disease , inclusion (mineral) , disease , public health , environmental health , gerontology , nursing , psychology , social psychology

Many countries are developing or refining national strategies for noncommunicable chronic disease (NCD) prevention and control. Chronic kidney disease (CKD) is a cause and consequence of other NCDs; CKD acts as a risk multiplier for all four key NCDs as specified by the World Health Organization; CKD is associated with high health-care costs; CKD is readily identifiable; and treatment of CKD is cost-effective and improves outcomes. These observations argue in favor of including CKD in national NCD programs. The purpose of this article is to outline key steps in advocating for the inclusion of CKD in national NCD strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research